Skip to main content

SAMSARA BIOCAPITAL, LLC

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1744967 PALO ALTO, CA

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$158,400,065
-$645,812 QoQ
Shares Held
5,871,018
0.0% QoQ
Ownership
6.64%
of shares outstanding
% of Portfolio
13.01%
of 13F equity value
Holder Rank
#4
of 224 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLYS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SAMSARA BIOCAPITAL, LLC holds $1,139,869,255 across 22 Biotechnology names. MLYS ranks #3 (13.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 MLYS
Mineralys Therapeutics, Inc.
This page
5,871,018 $158,400,065

All Filings in MLYS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $158,400,065 5,871,018
2026-03-31 $159,045,877 5,871,018
2025-12-31 $213,059,243 5,871,018
2025-09-30 $237,498,685 6,263,151
2025-06-30 $76,781,613 5,674,916
2025-03-31 $90,117,666 5,674,916
2024-12-31 $62,472,215 5,074,916
2024-09-30 $61,457,232 5,074,916
2024-06-30 $59,376,517 5,074,916
2024-03-31 $65,517,165 5,074,916
2023-12-31 $38,866,504 4,519,361
2023-09-30 $42,979,123 4,519,361
2023-06-30 $77,055,105 4,519,361
2023-03-31 $70,773,193 4,519,361